<input id="c6cqi"><object id="c6cqi"></object></input>
  • <samp id="c6cqi"><label id="c6cqi"></label></samp>

    Abcam news

    Nov-2019

    Abcam delivers outstanding performance in new Biocompare antibody market report

    Nov-2019

    Scientists poised to unlock their understanding of autophagy with new antibody-based insights

    Nov-2019

    Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment

    Nov-2019

    Abcam and BrickBio announce a partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam's portfolio

    Nov-2019

    Engineered knockout cell lysates for reproducible proteomic analysis

    Jul-2019

    Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio

    May-2019

    New tissue clearing kits and reagents for faster, accurate 3D imaging

    Apr-2019

    NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler

    Mar-2019

    Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging

    Mar-2019

    Abcam wins the UK-China Business award

    Feb-2019

    Abcam moves to new purpose-built global headquarters

    Feb-2019

    Dr Michael Weiner wins CiteAb’s 2019 Lifetime achievement award

    Jan-2019

    Abcam expands custom services capabilities with the acquisition of Calico Biolabs

    Jan-2019

    Abcam and the LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder

    Dec-2018

    QIAGEN (Suzhou) and Abcam sign strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market

    Dec-2018

    Abcam 'Most Admired Company' award

    Oct-2018

    Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development

    Oct-2018

    New PBS-only antibodies enable more flexible research

    Jul-2018

    Abcam Merck collaboration produces new PD-L1 antibody for immuno-oncology research

    Jun-2018

    Congratulations to Alan Hirzel, winner of European Mediscience Awards Chief Executive of the year award

    Apr-2018

    Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development

    Feb-2018

    New CatchPoint? SimpleStep? ELISA fluorescent 90-minute assay

    Feb-2018

    Introducing FirePlex?-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples

    Feb-2018

    Abcam and Molecular Devices announce strategic collaboration

    Jan-2018

    Abcam wins another CiteAb award

    Jan-2018

    Abcam signs exclusive license agreement with Roche

    Aug-2017

    Abcam and TTP Labtech collaborate to develop sol-R reagent kits

    Jul-2017

    The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins

    Jun-2017

    Abcam announces first international Epigenetics conference in South Korea

    Jan-2017

    Abcam wins two CiteAb awards

    Nov-2016

    Abcam wins Best Careers Website at the In-house Recruitment Awards

    Jul-2016

    New multiplex immunoassays with Firefly? particle technology

    Apr-2016

    Abcam enables faster drug and biomarker discovery with immunoassay research suite

    Feb-2016

    Congratulations to Jonathan Milner, winner of CiteAb’s Lifetime achievement award

    Nov-2015

    Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers

    Nov-2015

    Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership

    Oct-2015

    Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research

    Sep-2015

    Abcam raises antibody validation standards to improve quality for life science researchers

    Jun-2015

    Appointment of Chief Legal Officer and Company Secretary

    Jun-2015

    Abcam launches multiplex miRNA profiling assays

    Jan-2015

    Abcam signs exclusive partnership agreement with A*STAR's Institute of Molecular and Cell Biology

    Dec-2014

    Sue Harris appointed as non-Executive Director on Abcam Board

    Dec-2014

    Abcam appoints Yvonne Chien as Chief Digital Officer

    Nov-2014

    Abcam wins 'Best Use of Digital Media' at Life Science Industry Awards

    Sep-2014

    Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute

    Sep-2014

    Abcam plc announces appointment of new CEO and Board changes

    Sep-2014

    Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb? antibodies

    Sep-2014

    Abcam introduces exclusive range of highly validated antibody conjugates

    Aug-2014

    Abcam establishes new direct service for Australia and New Zealand

    Jun-2014

    Abcam's CEO wins Mediscience award

    Mar-2014

    Abcam introduces Alexa Fluor? 680/790 secondary antibodies for fluorescent western blotting

    Feb-2014

    Abcam Announces Winner of 15 Discoveries Contest

    Jan-2014

    Abcam to open office in Shanghai, China

    Dec-2013

    Abcam wins 'Most Admired Company' award

    Nov-2013

    Abcam Introduces Alexa Fluor Secondary Antibodies

    Oct-2013

    Abcam Named AIM Company of the Year

    Sep-2013

    Abcam Launches SimpleStep ELISA Kits

    Jun-2013

    Abcam appoints Alan Hirzel as Chief Marketing Officer

    Apr-2013

    Abcam Welcomes Students from Cambridge Regional College

    Mar-2013

    Abcam donates an additional £45,000 to local charities

    Dec-2012

    Abcam helps contribute to growth of hi-tech sector in Cambridge, UK

    Nov-2012

    We have reached 100,000 products

    Oct-2012

    HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action

    Sep-2012

    Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics

    Jan-2012

    New range of Biochemicals now available from Abcam

    Sep-2011

    Abcam acquires Ascent Scientific, a specialist provider of biochemicals

    May-2011

    Abcam acquires MitoSciences in deal which enhances immunoassay portfolio

    Nov-2010

    Jonathan Milner wins Entrepreneur of the Year award.

    Jul-2010

    Abcam's Jonathan Milner wins CEO of the Year

    Jul-2010

    300th employee hired

    Mar-2010

    Abcam wins 'Business of the Year 2009' at the Business Weekly East of England Awards.

    Feb-2010

    Abcam founder wins 'CEO of the Year' at Quoted Company Awards 2010

    Jan-2010

    Abcam and Cambridge Design Partnership develop innovative labeling solution

    Oct-2009

    Abcam named 'Company of the Year' at 2009 AIM Awards

    Jun-2009

    Abcam’s expansion continues with its fourth move on the Cambridge Science Park

    Nov-2008

    Winners of tenth anniversary competition announced

    Jul-2008

    200th employee hired

    May-2008

    Licensing deal signed with Tepnel Life Sciences

    Mar-2008

    Grand setting for Japanese sub-dealer meetings

    Nov-2007

    Automated system to expand monoclonal production

    Nov-2007

    Abcam and leading antibody producer collaborate to make 12,000 rabbit polyclonals

    Nov-2007

    CLC bio customized software supports Abcam's monoclonal development capability

    Nov-2007

    Jeffrey Iliffe appointed as Chief Financial Officer

    May-2007

    Same day delivery in Cambridge UK

    Mar-2007

    Over 30,000 products in our catalog

    Mar-2007

    Abcam to partner in the EPITRON project

    Jan-2007

    $2 to Médecins Sans Frontières for every new registration

    Jul-2006

    Extra Abpoints introduced for first Abreviews

    Jul-2006

    Appointment of Non-Executive Directors

    Jun-2006

    Winner of Best Newcomer in the UK techMARK mediscience awards

    May-2006

    Better antibodies, faster

    Feb-2006

    Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005

    Feb-2006

    20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news

    Jan-2006

    Fast Abpromise support, free loading control samples, Abupdate & news

    Nov-2005

    Search filter, conjugated loading controls, Abupdate & news

    Oct-2005

    Extended North America customer service hours

    Sep-2005

    Top forty position, Sunday Times Microsoft Tech Track

    May-2005

    US office on the move

    Apr-2005

    Queen's Award at first attempt

    Apr-2005

    More space

    Dec-2004

    A faster service

    Oct-2004

    First place in Deloitte's Fast 50

    Sep-2004

    50th employee hired

    Sep-2004

    Top forty position, Sunday Times Microsoft Tech Track

    Jun-2004

    Jim Warwick becomes Managing Director (Abcam Ltd)

    Feb-2004

    Collaboration deal struck with Purely Proteins

    Jan-2004

    A New Year's Honour

    Dec-2003

    High growth status recognised again, this time nationally

    Oct-2003

    Success in Deloitte's Regional Technology Fast 50

    Sep-2003

    Top twenty position, Sunday Times Arm Tech Track

    Jul-2003

    British royalty visits Abcam

    May-2003

    First overseas office established

    Apr-2003

    Jim Warwick (Technical Director) becomes full-time

    Mar-2003

    CEN Business Excellence Awards winner

    Mar-2003

    25th employee hired

    Feb-2003

    On the move again

    Nov-2002

    Deloitte Top 50 regional winner

    Aug-2002

    FedEx tie-up boosts customer support services

    Jun-2001

    Technical Director appointed

    May-2001

    UK Online for Business Award, highly commended

    Oct-2000

    CEN Millennium Business Excellence Awards finalist

    May-2000

    10th employee hired

    Apr-2000

    Finance Director appointed

    Mar-2000

    New premises on the Cambridge Science Park

    Oct-1999

    First (of many) awards

    Oct-1998

    Open for business

    Sign up
    青青青手机免费视频